Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C8H6N2 |
| Molecular Weight | 130.1466 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C1=CC=C2N=CC=NC2=C1
InChI
InChIKey=XSCHRSMBECNVNS-UHFFFAOYSA-N
InChI=1S/C8H6N2/c1-2-4-8-7(3-1)9-5-6-10-8/h1-6H
| Molecular Formula | C8H6N2 |
| Molecular Weight | 130.1466 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Quantitative structure-activity relationships for small non-peptide antagonists of CXCR2: indirect 3D approach using the frontal polygon method. | 2006-01-15 |
|
| Synthesis and luminescence properties of U-shaped polycyclic molecules containing syn-facial functionalized quinoxaline rings. | 2005-10-27 |
|
| Investigation of the separation of heterocyclic aromatic amines by reversed phase ion-pair liquid chromatography coupled with tandem mass spectrometry: the role of ion pair reagents on LC-MS/MS sensitivity. | 2005-10-25 |
|
| Novel cyclophilin D inhibitors derived from quinoxaline exhibit highly inhibitory activity against rat mitochondrial swelling and Ca2+ uptake/ release. | 2005-10 |
|
| Efficient solid-phase-based total synthesis of the bisintercalator TANDEM. | 2005-09-16 |
|
| Proton driven vase-to-kite conformational change in cavitands at an air-water interface monitored by surface SHG. | 2005-08-02 |
|
| Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivatives. | 2005-07-01 |
|
| Prediction of genotoxicity of chemical compounds by statistical learning methods. | 2005-06 |
|
| DNA damage induced by a quinoxaline 1,4-di-N-oxide derivative (hypoxic selective agent) in Caco-2 cells evaluated by the comet assay. | 2005-05 |
|
| Synthesis and characterization of p-phenylenediamine derivatives bearing an electron-acceptor unit. | 2005-04-01 |
|
| Replacement of active-site residues of quinoline 2-oxidoreductase involved in substrate recognition and specificity. | 2005-04 |
|
| Quinoxaline 1,4-dioxides induce G2/M cell cycle arrest and apoptosis in human colon cancer cells. | 2005-04 |
|
| [Studying the efficacy of a series of quinoxaline and azolo[a(b)]quinoxaline derivatives as P2X receptor antagonists]. | 2005-03-25 |
|
| Iridium(III) complexes with orthometalated quinoxaline ligands: subtle tuning of emission to the saturated red color. | 2005-03-07 |
|
| Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP-ribose) polymerase-1/2 inhibitors. | 2005-02-28 |
|
| Part 3: synthesis and biological evaluation of some analogs of the antitumor agents, 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid, and 2-{4-[(7-bromo-2-quinolinyl)oxy]phenoxy}propionic acid. | 2005-02-15 |
|
| Functional cross-talk between fatty acid synthesis and nonribosomal peptide synthesis in quinoxaline antibiotic-producing streptomycetes. | 2005-02-11 |
|
| Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties. | 2005-02-10 |
|
| [New methyl-quinoxaline derivatives with antimicrobial activity]. | 2005-02-04 |
|
| In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria. | 2005-02 |
|
| Water-soluble benzoheterocycle triosmium clusters as potential inhibitors of telomerase enzyme. | 2005-02 |
|
| On the microscopic theory of polar solvation dynamics. | 2005-01-22 |
|
| Reactivity and transformation of antibacterial N-oxides in the presence of manganese oxide. | 2005-01-15 |
|
| Quinoxaline 1,4-dioxide: a versatile scaffold endowed with manifold activities. | 2005 |
|
| Selective toxicity of a quinoxaline 1,4-di-N-oxide derivative in human tumour cell lines. | 2005 |
|
| Immunochemical detection of 3-deoxyglucosone in serum. | 2004-12-17 |
|
| Lewis acid-promoted annulation of O-quinonediimines by allylstannane: a facile synthesis of quinoxaline derivatives. | 2004-12-09 |
|
| Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries. | 2004-10-01 |
|
| The effect of oxythioquinox exposure on normal human mammary epithelial cell gene expression: a microarray analysis study. | 2004-09-23 |
|
| Hypoxic cells in tumors as a target for cancer therapy. | 2004-08-10 |
|
| A new family of quinoline and quinoxaline analogues of combretastatins. | 2004-07-16 |
|
| Occurrence of antimicrobials in the final effluents of wastewater treatment plants in Canada. | 2004-07-01 |
|
| The influence of intercalator binding on DNA triplex stability: correlation with effects on A-tract duplex structure. | 2004-07-01 |
|
| Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives. | 2004-07-01 |
|
| Zn(II)-induced conformational control of amphiphilic cavitands in langmuir monolayers. | 2004-06-21 |
|
| Solution-phase synthesis of nucleobase-substituted analogues of triostin A. | 2004-05-28 |
|
| Lead discovery of quinoxalinediones as an inhibitor of dipeptidyl peptidase-IV (DPP-IV) by high-throughput screening. | 2004-05-17 |
|
| Co-targeting IGF-1R and c-kit: synergistic inhibition of proliferation and induction of apoptosis in H 209 small cell lung cancer cells. | 2004-05-04 |
|
| Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation. | 2004-05 |
|
| Thermodynamic properties of quinoxaline-1,4-dioxide derivatives: a combined experimental and computational study. | 2004-04-16 |
|
| [How have we found any new reactions in the field of the heterocyclic chemistry?]. | 2004-04 |
|
| Design and synthesis of novel imidazo[1,2-a]quinoxalines as PDE4 inhibitors. | 2004-03-01 |
|
| Quinoxaline chemistry. Part XVII. Methyl [4-(substituted 2-quinoxalinyloxy) phenyl] acetates and ethyl N-([4-(substituted 2-quinoxalinyloxy) phenyl] acetyl) glutamates analogs of methotrexate: synthesis and evaluation of in vitro anticancer activity. | 2004-03 |
|
| Successive determination of thiamine and ascorbic acid in pharmaceuticals by flow injection analysis. | 2004-02-18 |
|
| Quinoxaline excision: a novel approach to tri- and diquinoxaline cavitands. | 2004-02-05 |
|
| Metal-assisted light-induced DNA cleavage activity of 2-(methylthio)phenylsalicylaldimine Schiff base copper(II) complexes having planar heterocyclic bases. | 2004-02 |
|
| Synthesis and Bergman cyclization of a beta-extended porphyrenediyne. | 2004-01-21 |
|
| Synthesis and biological activity of new quinoxaline antibiotics of echinomycin analogues. | 2004-01-19 |
|
| Photophysical processes in quinoxaline vapor at low pressure. | 2003-11 |
|
| Metal-assisted red light-induced efficient DNA cleavage by dipyridoquinoxaline-copper(II) complex. | 2003-10-07 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:18:25 GMT 2025
by
admin
on
Mon Mar 31 19:18:25 GMT 2025
|
| Record UNII |
QM4AR6M6T8
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
QUINOXALINE
Created by
admin on Mon Mar 31 19:18:25 GMT 2025 , Edited by admin on Mon Mar 31 19:18:25 GMT 2025
|
PRIMARY | |||
|
m9465
Created by
admin on Mon Mar 31 19:18:25 GMT 2025 , Edited by admin on Mon Mar 31 19:18:25 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID6049432
Created by
admin on Mon Mar 31 19:18:25 GMT 2025 , Edited by admin on Mon Mar 31 19:18:25 GMT 2025
|
PRIMARY | |||
|
202-047-4
Created by
admin on Mon Mar 31 19:18:25 GMT 2025 , Edited by admin on Mon Mar 31 19:18:25 GMT 2025
|
PRIMARY | |||
|
QM4AR6M6T8
Created by
admin on Mon Mar 31 19:18:25 GMT 2025 , Edited by admin on Mon Mar 31 19:18:25 GMT 2025
|
PRIMARY | |||
|
91-19-0
Created by
admin on Mon Mar 31 19:18:25 GMT 2025 , Edited by admin on Mon Mar 31 19:18:25 GMT 2025
|
PRIMARY | |||
|
7045
Created by
admin on Mon Mar 31 19:18:25 GMT 2025 , Edited by admin on Mon Mar 31 19:18:25 GMT 2025
|
PRIMARY | |||
|
36616
Created by
admin on Mon Mar 31 19:18:25 GMT 2025 , Edited by admin on Mon Mar 31 19:18:25 GMT 2025
|
PRIMARY |